Back
to sessions
Oct 01
Quick Pitch
QP 19 - GI 4: Quick Pitch: Enhancing Efficacy for Esophageal Cancer and Radiation Responders for Rectal Cancer
Credits
| AMA PRA Category 1 Credits: | 1.00 |
| CAMPEP Credits: | 1.00 |
| MDCB Credits: | 1.00 |
Presentations
-
08:00am - 08:05am PT
Introduction
Speaker: Julie Koenig, MD - Mass General Brigham, Somerville -
08:05am - 08:10am PT
-
08:10am - 08:15am PT
Radiotherapy followed by Systemic Therapy and Tislelizumab in MSS Rectal Cancer with Unresectable Metastases: Results of the MIRACLE-2 Study
Speaker: Zhen Zhang, MD, PhD - Fudan University Shanghai Cancer Center, shanghai -
08:15am - 08:20am PT
Genetic Variants and Immunotherapy-Combined Modality Correlates with Neoadjuvant Therapy Outcomes in Microsatellite-Stable Rectal Cancer
Speaker: Zhen Zhang, MD - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai -
08:20am - 08:25am PT
Peripheral Blood Immune Cell Dynamics as Indicators and Predictors of Clinical Response to Immunotherapy Based Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer
Speaker: Yaqi Wang, MD - Fudan University Shanghai Cancer Center, Shanghai -
08:25am - 08:30am PT
Long-Term Outcomes of Dose Escalation in Definitive Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized Phase III Trial
Speaker: Yujin Xu, MD, PhD - Zhejiang Cancer Hospital, Hangzhou -
08:30am - 08:35am PT
Endoscopic Ultrasound Fine Needle Injection of NBTXR3 Activated by Radiotherapy with Concurrent Chemotherapy for Adenocarcinoma of the Esophagus: Feasibility and Safety of the Phase I Dose Escalation Part for the Photon-Based Cohort
Speaker: Steven Lin, MD, PhD, FASTRO - The University of Texas MD Anderson Cancer Center, Houston -
08:35am - 08:55am PT
Question and Answers
Speaker: Jonathan Ashman, MD, PhD, FASTRO - Mayo Clinic, Phoenix -
08:55am - 09:00am PT
Closing
Speaker: Julie Koenig, MD - Mass General Brigham, Somerville